Sign In
Get Started →
Bill Boyle
Antibody Therapeutics
Summary
Dr. Bill Boyle is a distinguished senior executive in the pharmaceutical and biotechnology industry with an impressive 28-year track record. He has held leadership positions in both private start-up ventures and multinational corporations. Presently, he is actively engaged as the Chief of Translational Medicine at BioAtla, LLC, and also holds the esteemed role of Associate Professor of Medicine at UCLA's David Geffen School of Medicine, where he leads the DGSOM CTSI Accelerator program.
This public profile is provided courtesy of Clay. All information found here is in the public domain.
This public profile is provided courtesy of Clay. All information found here is in the public domain.